Investment in Glucose Responsive Insulins Altering the Diabetes Market Landscape

(Nashua, NH) – As the number of patients diagnosed with diabetes continues to climb worldwide, drug developers and researchers are attempting to identify more effective ways to control glucose levels. Over the years, new medicines based on novel therapeutic moieties with potentially unique benefits have attracted attention and research emphasis. A recent wave of investment and developmental activity now seems to be heralding in what may be a new era in the treatment of insulin-dependent diabetes, perhaps as game-changing as the first availability of synthetic human insulin fifty years ago.

A number of companies are exploring ways to modify insulin to allow it to respond to patient glucose levels. If successful, these glucose responsive insulins would provide relief from the hypo/hyperglycemic cycle that diabetic patients must be constantly vigilant about. The entry into the market segment of most of the major insulin suppliers is creating credibility for this complex approach to glycemic control, as well as raising patient and investor expectations. At the same time, the alignment of most majors with IP owners leaves few chairs available when the music stops for the remaining independents, which must now develop alternative strategies for the downstream funding of glucose responsive insulin projects.

Applied Data Research has just published a new report detailing the findings of a just-completed survey of this ambitious development segment. Glucose Responsive Insulins has been researched and written to be of optimal value to diabetes market sector participants. It consists of in-depth analyses, descriptions and evaluations of modified insulin development activity, technology issues, business factors and market sector profiles.

More information is available at applieddata.org

Source: Applied Data Research

About Applied Data Research

Applied Data Research is a technology consulting firm focused on the areas of technology strategy, product commercialization, venture development, and market research. We assist technology companies in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

Contact:

Greg Stone
98 Amherst St.
Amherst, NH 03031 USA
Voice: 603-718-4564
grstone@applieddata.org
www.applieddata.org

This release was published on openPR.